Clenbuterol affects the expression of messenger RNA for interleukin 10 in peripheral leukocytes from horses challenged intrabronchially with lipopolysaccharides

Veterinary Research Communications

Volumn 30, Issue 8, 2006, Pages 921-928

  Hoven, Rene ^a   Duvigneau, J C ^a   Hartl, R T ^a   Gemeiner, M ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Clenbuterol; Interleukin 10; Leukocytes; Lipopolysaccharides; Recurrent airway obstruction

Indexed keywords

CLENBUTEROL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL WELFARE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; HORSE; IMMUNOMODULATION; INHALATION TEST; LEUKOCYTE; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRONCHODILATOR AGENTS; CLENBUTEROL; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; INTERLEUKIN-10; LEUKOCYTES; LIPOPOLYSACCHARIDES; LUNG DISEASES, OBSTRUCTIVE; MALE; RNA, MESSENGER;

EQUIDAE;

EID: 33846838594     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-006-3383-4     Document Type: Article

References (17)

1. Bull, S., Laan, T., de Vrieze, G., Spee, B., van den Hoven, R. and Fink-Gremmels, J., 2003. Modulation of LPS-induced cytokine production by clenbuterol in equine macrophages Journal of Veterinary Pharmacology and Therapeutics, 26(suppl.1) Proceedings of the 9th International Congress of the EAVPT, 234
2. Colahan, P.T., Kollias-Bakert, C., Leutenegger, C.M. and Jones, J.H., 2002. Does training affect mRNA transcription for cytokine production in circulating leucocytes? Equine Veterinary Journal, (Supplement), 34, 154-158
3. Fogelmark, B., Yuasa, K. and Rylander, R., 1992. Acute pulmonary toxicity of inhaled beta-1 3 glucan and endotoxin, Agents And Actions, 35, 50-56
4. Giguère, S., Viel, L. Lee, E., MacKay, R.J., Hernandez, J., Franchini, M., 2002. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Veterinary Immunology and Immunopathology, 85, 147-158
5. Hoffman, A.M., 1999. Bronchoalveolar lavage technique and cytological diagnosis of small airway inflammatory disease. Equine Veterinary Education, 11, 330-336
6. Izeboud, C.A., Mocking, J.A., Monshouwer, M., van Miert, A.S.J.P.A.M. and Witkamp, R.F., 1999. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. Journal of Receptor and Signal Transduction Research, 19, 191-202
7. Joubert, P., Silversides, D.W. and Lavoie, J.-P., 2001. Equine neutrophils express mRNA for tumor necrosis factor, interleukin (IL)-1β, IL-6, IL-8, macrophage-inflammatory-protein-2 but not for IL-4, IL-5 and interferon-γ. Equine Veterinary Journal, 33, 730-733
8. Lavoie, J. P., Maghni, K., Desnoyers, M., Taha, R., Martin, J.G. and Hamid, Q.A., 2001. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American Journal of Respiratory and Critical Care Medicine, 164, 1410-1413
9. Lim, W.-S., Edwards, J.F., Boyd, N.K., Payne, S.L., and Ball, J.M., 2003. Simultaneous quantitation of equine cytokine mRNAs using a multi-probe ribonuclease protection assay. Veterinary Immunology and Immunopathology, 91, 45-51
10. Mair, T.S. and Derksen, F.J. 2000. Chronic obstructive pulmonary disease: A review. Equine Veterinary Education 12, 35-44
11. Pedersen, L.G., Castelruiz, Y., Jacobsen, S. and Aasted, B., 2002. Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Veterinary Immunology and Immunopathology, 88, 111-122
12. Pirie, R.S., Dixon, P.M., Collie, D.D.S. and McGorum, B.C., 2001. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Veterinary Journal, 33, 311-318
13. Sasse, H.L. and Hajer, R., 1978. NAB 365, a beta2-receptor sympathomimetic agent: Clinical experience in horses with lung disease. Journal of Veterinary Pharmacology and Therapeutics, 1, 241-244
14. Stadler, P. and Deegen, E., 1986. Diurnal variation of dynamic compliance, resistance and viscous work of breathing in normal horses and horses with lung disorders. Equine Veterinary Journal, 18, 171-178
15. Swiderski, C.E., Klei, T.R. and Horohov, D.W., 1999. Quantitative measurement of equine cytokine mRNA expression by polymerase chain reaction using target-specific standard curves. Journal of Immunological Methods, 222, 155-169
16. Van den Hoven, R., Duvigeau, J. C., Hartl, R.T., Riedelberger, K., Teinfalt, M. and Gemeiner, M., 2004. The expression of mRNA for tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, IL-10, tissue growth factor-β and interferon-γ in BALF cells from horses challenged with LPS and treated with clenbuterol. Journal of Equine Veterinary Science, 24, 29-36
17. Van Miert, A.S.J.P.A.M., 2002. Present concepts on the inflammatory modulators with special reference to cytokines. Veterinary Research Communications, 26, 111-126